Filters
Close
ADDED DATE
Added date
AUTHOR Please select
TOPICS Please select
WATCH / LISTEN / READ TIME
Author(s): Gerald V Naccarelli , Deborah L Wolbrette , Mazhar Khan , et al Added: 3 years ago
Abstract Prospective trials have demonstrated that flecainide, propafenone, quinidine, and sotalol are equally effective in preventing recurrences of atrial fibrillation (AF). A new twice-a-day formulation of propafenone has been demonstrated to have efficacy that is higher than the short-acting form of the drug. Dofetilide, although useful for terminating and preventing recurrence of persistent… View more
Author(s): James A Reiffel Added: 3 years ago
Atrial fibrillation (AF) is the most frequent serious arrhythmia encountered in clinical practice. It is usually symptomatic; can reduce quality of life; commonly results in hospitalization; typically requires multiple drugs in its treatment; and can result in heart failure, embolization and its consequences, and death. Even when AF itself does not directly provoke symptoms leading to its… View more
Author(s): Oussama M Wazni , Andrea Natale Added: 3 years ago
Atrial fibrillation (AF) affects approximately two million people in the US. It is a major cause of stroke, adversely impacts quality of life, and is associated with increased mortality.1-4 Treatment with antiarrhythmic drugs and anticoagulation is still considered first-line therapy in patients with symptomatic AF. Recent randomized trials4,5 have shown that a strategy of rate control and… View more
Author(s): Gerald V Naccarelli , Deborah L Wolbrette , Mazhar Khan , et al Added: 3 years ago
Prospective trials have demonstrated that flecainide, propafenone, quinidine, and sotalol are equally effective in preventing recurrences of atrial fibrillation (AF). A new twice-a-day formulation of propafenone has been demonstrated to have efficacy that is higher than the short-acting form of the drug. Dofetilide, although useful for terminating and preventing recurrence of persistent AF, has… View more
Author(s): Andrea Natale , Dimpi Patel Added: 3 years ago
Atrial fibrillation (AF) is the most common sustained arrhythmia and is associated with an increased risk of morbidity and mortality. A subanalysis of the Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) suggests that there is a significant survival benefit in the maintenance of sinus rhythm (SR), if it can be achieved without the potential adverse effects associated with… View more
Author(s): Robert Hebeler Added: 3 years ago
Since its introduction in 1987, the Maze procedure has been regarded as the 'gold standardÔÇÖ for the surgical treatment of atrial fibrillation (AF). However, the complexity of the procedure has restricted its adoptability in the surgical community and provided an impetus for the development of less complex operations for the effective treatment of AF. The absolute number of patients who have… View more
Author(s): Charalampos Kriatselis Added: 3 years ago
Atrial fibrillation (AF) is the most common form of cardiac arrhythmia and is associated with high rates of morbidity and mortality.1 AF can be paroxysmal or persistent, and remains asymptomatic in some cases. However, in more severe and persistent cases AF may cause congestive heart failure, palpitations, syncope, and chest pains. Additionally, patients with AF have a significantly higher risk… View more
Author(s): Paul A Friedman , Stephen C Hammill Added: 3 years ago
Atrial fibrillation (AF) is a rhythm disturbance of the atria that results in irregular, chaotic, ventricular waveforms, varying from bradyarrhythmia to tachyarrhythmia. Essentially, all forms of AF therapy can be divided into two categories - restoration and maintenance of normal sinus rhythm, or control of the ventricular rate while permitting on-going fibrillation of the atria. Although… View more
Author(s): Oussama M Wazni , Andrea Natale Added: 3 years ago
Atrial fibrillation (AF) affects approximately two million people in the US. It is a major cause of stroke, adversely impacts quality of life, and is associated with increased mortality.1-4 Treatment with antiarrhythmic drugs and anticoagulation is still considered first-line therapy in patients with symptomatic AF. Recent randomized trials4,5 have shown that a strategy of rate control and… View more
Author(s): Paul A Friedman , Stephen C Hammill Added: 3 years ago
Atrial fibrillation (AF) is a rhythm disturbance of the atria that results in irregular, chaotic, ventricular waveforms, varying from bradyarrhythmia to tachyarrhythmia. Essentially, all forms of AF therapy can be divided into two categories - restoration and maintenance of normal sinus rhythm, or control of the ventricular rate while permitting on-going fibrillation of the atria. Although… View more